Janssen Owes Additional $1.5B In HIV Prescription Trial
By Cara Salvatore · March 28, 2025, 9:24 PM EDT
A New Jersey federal judge on Friday added nearly $1.3 billion in penalties and $240 million in damages to a whistleblower False Claims Act verdict against Janssen over the off-label marketing...
To view the full article, register now.